- Telehealth Visits
- Insurance plan information
Emily Kantoff, NP
She | Her | HersHematology Oncology- Telehealth Visits
- Insurance plan information
Emily Kantoff, NP
She | Her | HersHematology Oncology- Telehealth Visits
- Insurance plan information
On this page
About me
Emily Kantoff is a psychiatric nurse practitioner who cares for patients with cancer. Her techniques include cognitive behavioral and existential psychotherapy as well as personalized medication management. Focusing on individual needs, she helps her patients cope, work on short- and long-term goals, and find meaning in their experiences. She is adept at addressing cancer-related symptoms, including anxiety, depression, grief, fatigue, cognitive changes and sleep disturbances.
Kantoff earned her master's degree in nursing at the University of Pennsylvania. In her teaching and research, she focuses on meeting the psychiatric needs of cancer patients and their families, with the goals of reducing distress and improving quality of life.
On weekends, Kantoff enjoys trailblazing hikes and e-bike adventures, as well as exploring fun culinary scenes and seeking some Zen through hot yoga. She loves reading, especially to advance her practice as a care provider.
Education & training
Board certification
- Adult Psychiatric and Mental Health Nurse Practitioner, American Nurses Credentialing Center
Degree
- MSN, University of Pennsylvania School of Nursing
My expertise
Specialties
Clinical Trials query: q=health_gateway_id_ss%3A%28%224581%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224581%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.